These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 17933567)
1. Visual Analogue Scale to score the effects of Botulinum Toxin A treatment in children with cerebral palsy in daily clinical practice. Vles GF; de Louw AJ; Speth LA; van Rhijn LW; Janssen-Potten YJ; Hendriksen JG; Vles JS Eur J Paediatr Neurol; 2008 May; 12(3):231-8. PubMed ID: 17933567 [TBL] [Abstract][Full Text] [Related]
2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis]. Wissel J; Entner T Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048 [TBL] [Abstract][Full Text] [Related]
3. Parent-proxy ratings of pain before and after botulinum toxin type A treatment for children with spasticity and cerebral palsy. Rivard PF; Nugent AC; Symons FJ Clin J Pain; 2009 Jun; 25(5):413-7. PubMed ID: 19454875 [TBL] [Abstract][Full Text] [Related]
4. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy. Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658 [TBL] [Abstract][Full Text] [Related]
5. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study]. Mousny M; Allington N Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416 [TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy. Lundy CT; Doherty GM; Fairhurst CB Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910 [TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy. Kaishou Xu ; Tiebin Yan ; Jianning Mai Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of spasticity in cerebral palsy with botulinum toxin]. Calderón-González R; Calderón-Sepúlveda RF Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892 [TBL] [Abstract][Full Text] [Related]
9. [Botulinum toxin type A in the treatment plan for cerebral palsy]. Strobl W Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal examination of health outcomes associated with botulinum toxin use in children with cerebral palsy. Balkrishnan R; Manuel JC; Smith BP; Camacho FT; Koman LA J Surg Orthop Adv; 2004; 13(2):76-80. PubMed ID: 15281403 [TBL] [Abstract][Full Text] [Related]
11. The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot study. Zelnik N; Giladi N; Goikhman I; Keren G; Moris R; Honigman S Isr J Med Sci; 1997 Feb; 33(2):129-33. PubMed ID: 9254875 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report. Opara J; Hordyńska E; Swoboda A Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin and cerebral palsy: time for reflection? Gough M; Fairhurst C; Shortland AP Dev Med Child Neurol; 2005 Oct; 47(10):709-12. PubMed ID: 16174320 [TBL] [Abstract][Full Text] [Related]
14. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE. Chaléat-Valayer E; Parratte B; Colin C; Denis A; Oudin S; Bérard C; Bernard JC; Bourg V; Deleplanque B; Dulieu I; Evrard P; Filipetti P; Flurin V; Gallien P; Héron-Long B; Hodgkinson I; Husson I; Jaisson-Hot I; Maupas E; Meurin F; Monnier G; Pérennou D; Pialoux B; Quentin V; Moreau MS; Schneider M; Yelnik A; Marque P Eur J Paediatr Neurol; 2011 Sep; 15(5):439-48. PubMed ID: 21745754 [TBL] [Abstract][Full Text] [Related]
15. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients. Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710 [TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy. Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821 [TBL] [Abstract][Full Text] [Related]
17. [Botulin toxin as treatment for spasticity and dystonia in infantile cerebral paralysis]. Aguilar-Rebolledo F; Hernández-Sánchez J; Rayo-Mares D; Soriano-Fonseca F; García-Muñoz L; Ruiz-Ponce J; Garrido-Ramírez E Gac Med Mex; 2001; 137(5):403-11. PubMed ID: 11692809 [TBL] [Abstract][Full Text] [Related]
18. Parent evaluation of spasticity treatment in cerebral palsy using botulinum toxin type A. Symons FJ; Rivard PF; Nugent AC; Tervo RC Arch Phys Med Rehabil; 2006 Dec; 87(12):1658-60. PubMed ID: 17141650 [TBL] [Abstract][Full Text] [Related]
19. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy. Crowner BE; Racette BA Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363 [TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts. Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]